Eric Easom
Fondatore presso AN2 THERAPEUTICS, INC.
Patrimonio netto: 3 M $ in data 30/04/2024
Posizioni attive di Eric Easom
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2019 | - |
| Amministratore Delegato | 01/11/2019 | - | |
| Fondatore | 01/02/2017 | - | |
| Presidente | 01/11/2019 | - | |
| Chagas Disease Foundation | Direttore/Membro del Consiglio | 01/06/2018 | - |
Resilient Biotics, Inc.
 Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Direttore/Membro del Consiglio | 01/02/2019 | - |
Storia della carriera di Eric Easom
Precedenti posizioni note di Eric Easom
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/02/2009 | 01/06/2017 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | 01/01/2013 | 01/01/2014 |
| Presidente | 01/01/2009 | 01/01/2013 | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Vendite & Marketing | 01/07/2007 | 01/01/2009 |
| Medimmune, Inc. | Vendite & Marketing | 01/04/2006 | 01/07/2007 |
Formazione di Eric Easom
| Kelley School of Business | Masters Business Admin |
| University of Louisville | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
Posizioni
| Director/Board Member | 4 |
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
| Chagas Disease Foundation | |
Resilient Biotics, Inc.
Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Commercial Services |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Borsa valori
- Insiders
- Eric Easom
- Esperienza
